Clearway Health provides specialty pharmacy services tailored to hospitals and health systems, focusing on program design, medication access, network expansion, and embedded clinical staff. Originating from Boston Medical Center Health System, the organization helps partners develop or enhance in-house specialty pharmacies, aiming to improve medication adherence, access for complex patients, and financial sustainability. Services include hands-on operational support, 340B program optimization, and integration with care teams to reduce barriers for vulnerable populations. It is used by health systems seeking to launch or strengthen specialty pharmacy programs with measurable clinical and financial outcomes.

Kalderos provides a drug discount management platform that helps stakeholders across the pharmaceutical ecosystem—such as manufacturers, covered entities, and state payers—monitor and resolve issues related to noncompliant drug discount claims. The platform uses AI and machine learning to analyze large volumes of claims data from Medicaid, commercial payers, and 340B programs to detect overlapping discounts and streamline compliance workflows. Kalderos supports direct communication between parties and offers tools like Truzo for organizing inquiries and strengthening audit processes. It is used by pharmaceutical companies and healthcare providers to reduce financial risk and maintain program integrity.

Macro Helix provides software and services for managing 340B drug pricing programs, with solutions designed for covered entities and contract pharmacies. Its core platform, 340B Architect, supports functions such as split billing, contract pharmacy administration, referral capture, audit preparation, and compliance monitoring. Additional tools include analytics for program performance, order optimization for central pharmacies, and management of manufacturer restrictions. Macro Helix is widely used by hospitals and health systems to maintain 340B compliance, improve operational efficiency, and support equitable access to medications.